AZD0780, AZD0780 Placebo
D7960C00012
Phase 3 small_molecule active
Quick answer
AZD0780, AZD0780 Placebo for Hyperlipidemia, Atherosclerotic cardiovascular disease is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Hyperlipidemia, Atherosclerotic cardiovascular disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active